Trademark Overview
On Thursday, November 3, 2022, a trademark application was filed for GRASSIMMUNE with the United States Patent and Trademark Office. The USPTO has given the GRASSIMMUNE trademark a serial number of 97661560. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, December 7, 2023. This trademark is owned by Allergy Therapeutics (UK) Limited. The GRASSIMMUNE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical, medical and veterinary preparations and substances for the treatment of allergies; Pharmaceutical substances and preparations for the diagnosis and treatment of allergic conditions; Vaccines; Allergy vaccines; Immunotherapy pharmaceutical preparations for medical purposes; Sanitary preparations for medical purposes; Dietetic food and substances adapted for medical and veterinary use; food for babies; Dietary supplements for human beings and animals; medical plasters, materials for medical dressings; Material for stopping teeth, dental wax; Disinfectants; Preparations for destroying vermin; Fungicides, herbicides
